CJ Cheiljedang (097950) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
24 Nov, 2025Executive summary
Overseas food sales grew 8% year-over-year, led by a turnaround in China, growth in Japan, and expansion in Europe/Australia, while Korea's packaged food market rapidly shifted online with a 33% increase in online sales now exceeding 20% share.
Bio business improved bulky amino acid performance due to global protectionism and anti-dumping tariffs in Europe, with lysine profit up in Europe and specialty amino acids focusing on arginine and histidine.
Feed and care segment achieved a profit turnaround, with operating profit up KRW 50.5bn year-over-year and improved profitability in Vietnam and Indonesia.
Financial highlights
Q1 2025 sales excluding logistics dropped 1.8% year-over-year to KRW 4.3625 trillion; OP fell 7.8% to KRW 246.3 billion; net profit declined 73% to KRW 26.9 billion due to higher corporate tax.
Including logistics, Q1 sales were KRW 7.2085 trillion (down 0.1% year-over-year); OP decreased 11% to KRW 333.2 billion; net profit was KRW 57 billion, down 62.9%.
Food sales grew 3% year-over-year to KRW 2.925 trillion, but OP dropped 30% to KRW 128.6 billion due to high raw material costs and lower gift set sales in Korea.
Bio sales declined 12% to KRW 895.4 billion; OP down 16% to KRW 82.5 billion.
Feed and care sales fell 8% to KRW 542.5 billion, but OP rose by over KRW 50 billion year-over-year to KRW 35.2 billion.
Logistics sales increased 2% to KRW 2.9926 trillion; OP dropped 22% to KRW 85.4 billion due to higher operational expenses from new initiatives.
Outlook and guidance
Q2 2025 sales growth projected in the low to mid single digits, with an OP margin of 6%.
Food Global expects normalization of U.S. dessert production, sustained growth in Japan/China, and continued expansion in Europe/Australia.
Food Korea anticipates growth via online transition and new products despite raw material cost pressures.
Bio expects profit improvement as favorable market conditions for bulky amino acids take effect.
Feed and care expects solid profit generation through full-scale feed sales, offsetting lower livestock prices in Indonesia.
Latest events from CJ Cheiljedang
- Overseas food growth offset by BIO weakness, resulting in net losses and cautious 2026 outlook.097950
Q4 20259 Feb 2026 - Q2 OP rose 14% on bio and overseas food gains; Q3 targets low sales growth, 6%-7% OP.097950
Q2 20242 Feb 2026 - Q3 OP rose as global, bio, and logistics gains offset Korea declines; Q4 outlook remains positive.097950
Q3 202415 Jan 2026 - Operating profit up 39% YoY in Q4, but net profit negative on impairments; dividend raised.097950
Q4 202430 Dec 2025 - Bio and feed & care weakness drove profit declines, but food and logistics grew.097950
Q3 202517 Dec 2025 - Overseas and bio growth offset weak domestic demand, lifting net profit despite lower operating profit.097950
Q2 202511 Nov 2025